Your session is about to expire
What is Teriflunomide
Approved as Treatment by the FDA
Teriflunomide, also known as Aubagio, is approved by the FDA for 1 uses which include Multiple Sclerosis .Effectiveness
When to interrupt dosage
The suggested measure of Teriflunomide is contingent upon the diagnosed condition. The amount of dosage is contingent upon the delivery approach (e.g. Tablet, film coated or Tablet - Oral) featured in the table beneath.Warnings
Teriflunomide ContraindicationsTeriflunomide Novel Uses: Which Conditions Have a Clinical Trial Featuring Teriflunomide?
193 active clinical trials are underway to investigate the potential of Teriflunomide to mitigate Multiple Sclerosis symptoms.Teriflunomide Reviews: What are patients saying about Teriflunomide?
Patient Q&A Section about teriflunomide
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.Is teriflunomide FDA approved?
"The U.S. Food and Drug Administration has approved teriflunomide, a once-daily pill, to treat relapsing forms of MS. This is the second oral disease-modifying therapy approved for the treatment of multiple sclerosis."
What does Aubagio do to your body?
"Tell your doctor right away if you have any new or worsening skin problems, such as a rash, blisters, peeling skin, redness, or itching.
Aubagio may cause severe skin reactions, including Stevens-Johnson syndrome, which can be life-threatening. If you experience any new or worsening skin problems, such as a rash, blisters, peeling skin, redness, or itching, you should contact your doctor immediately."
Is teriflunomide an immunosuppressant?
"The results of the study showed that Teriflunomide and Cladribine are both effective in treating MS patients. Teriflunomide, in particular, was shown to reduce the annualized relapse rate (ARR) by more than 30% and disability progression by 30% compared to placebo."
What is teriflunomide used for?
"This medicine is used to treat the relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. This medicine will not cure MS, but it may slow some disabling effects and decrease the number of relapses of the disease."